Benzinga | Nov 12, 2020 04:23PM EST

aTyr Pharma Q3 EPS $(0.68) Beats $(0.74) Estimate, Sales $148.00K Beat $100.00K Estimate

aTyr Pharma (NASDAQ:LIFE) reported quarterly losses of $(0.68) per share which beat the analyst consensus estimate of $(0.74) by 8.11 percent. This is a 53.74 percent increase over losses of $(1.47) per share from the same period last year. The company reported quarterly sales of $148.00 thousand which beat the analyst consensus estimate of $100.00 thousand by 48.00 percent. This is a 19.57 percent decrease over sales of $184.00 thousand the same period last year.